Internal Medicine, Hematology & Oncology · Eugene, OR
NPI
1770979098
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
520 Country Club Pkwy
Eugene, OR, 97401
Phone (541) 683-5001
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.1M
120,131 services
Medicare patients, 2024
555
Average age 74
Drug cost, 2024
$4.7M
1,686 prescriptions
Company payments, 2025
$14K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Luke B Fletcher was code Q5110 (injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram), 12,060 times for 17 patients. In total Luke B Fletcher billed 120,131 services in 182 codes, and Medicare paid $2.1M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-15.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 12,060 | 17 | $0.22 | $2,655 |
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 10,500 | 13 | $0.88 | $9,242 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 9,300 | 20 | $44.64 | $415K |
| J0185 Injection, aprepitant, 1 mg | Office | 9,230 | 40 | $1.33 | $12K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 5,710 | 13 | $2.28 | $13K |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 5,220 | 13 | $39.41 | $206K |
| J9267 Injection, paclitaxel, 1 mg | Office | 2,590 | 13 | $0.07 | $180 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,190 | 57 | $0.09 | $106 |
| 85025 Blood Count | Office | 1,121 | 284 | $7.52 | $8,433 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 980 | 34 | $0.24 | $239 |
| Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 920 | 12 | $15.77 | $15K |
| 80053 Clinical Chemistry | Office | 915 | 274 | $10.20 | $9,337 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 910 | 56 | $0.66 | $604 |
| 36415 Venipuncture Blood Collection | Office | 807 | 285 | $8.61 | $6,948 |
| 96375 Injection Administration | Office | 370 | 97 | $11.74 | $4,345 |
By year: 2022 $1.4M for 97,400 services; 2023 $1.3M for 96,672 services; 2024 $2.1M for 120,131 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,121 | 284 | $7.52 | $8,433 |
| 80053 Clinical Chemistry | 915 | 274 | $10.20 | $9,337 |
| 36415 Venipuncture Blood Collection | 807 | 285 | $8.61 | $6,948 |
| 83520 Immunoassay | 128 | 32 | $16.93 | $2,166 |
| 84100 Clinical Chemistry | 126 | 15 | $4.65 | $586 |
| 82728 Clinical Chemistry | 125 | 61 | $13.28 | $1,660 |
| 83550 Clinical Chemistry | 115 | 57 | $8.52 | $979 |
| 83540 Clinical Chemistry | 114 | 56 | $6.30 | $718 |
| 82784 Immunoassay | 105 | 16 | $9.11 | $957 |
| 83615 Clinical Chemistry | 104 | 66 | $5.92 | $616 |
Medicare prescription drug claims, 2024
In 2024, the drug Luke B Fletcher prescribed most often to Medicare patients was Acyclovir, with 175 prescriptions and refills. In total Luke B Fletcher wrote 1,686 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 175 | 259 | 50 | $2,323 |
| Hydroxyurea Generic | 110 | 190 | 32 | $2,478 |
| Prochlorperazine Maleate Generic | 97 | 97 | 47 | $976 |
| Ondansetron Odt Ondansetron | 68 | 74 | 44 | $1,367 |
| Dexamethasone Generic | 61 | 70 | 24 | $1,287 |
| Letrozole Generic | 54 | 92 | Under 11 | $992 |
| Anastrozole Generic | 45 | 103 | 16 | $493 |
| Oxycodone Hcl Generic | 44 | 44 | 20 | $773 |
| Lenalidomide Generic | 44 | 44 | 13 | $585K |
| Levofloxacin Generic | 40 | 42 | 16 | $426 |
| Jakafi Ruxolitinib Phosphate | 35 | 35 | Under 11 | $604K |
| Eliquis Apixaban | 34 | 43 | 11 | $24K |
| Potassium Chloride Generic | 34 | 37 | 13 | $1,507 |
| Venclexta Venetoclax | 30 | 30 | 14 | $395K |
| Prednisone Generic | 30 | 32 | 15 | $158 |
Brand drugs: - claims; generic drugs: 1,392 claims; opioid claims: 92.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Luke B Fletcher $14K ($14K in general payments such as food, travel and fees and $240 for research) from 16 companies. The largest payer was Novartis Pharmaceuticals Corporation with $3,988.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 2 | $3,988 |
| PharmaEssentia USA Corporation 6446.TW | 1 | $2,610 |
| Astellas Pharma US Inc 4503.T | 1 | $2,172 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $2,100 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $1,191 |
| Abbvie Inc. ABBV | 3 | $713 |
| Taiho Oncology, Inc. 4578.T | 3 | $355 |
| F. Hoffmann-La Roche AG ROG.SW | 1 | $240 |
| Servier Pharmaceuticals LLC | 1 | $140 |
| Eli Lilly and Company LLY | 1 | $100 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.